Wakefield Asset Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
KCM
CC
Wakefield Asset Management's DVAX Position: Q2 2024 in Review
Wakefield Asset Management sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 59,637 shares — an estimated $740K sold.
Wakefield Asset Management first reported a position in DVAX in Q1 2021 and held it in 3 quarters. The position peaked at $828K in Q4 2023. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.
- Wakefield Asset Management reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
- Wakefield Asset Management sold 59,637 Dynavax Technologies shares in Q2 2024, an estimated $740K.
- Wakefield Asset Management first reported a position in Dynavax Technologies in Q1 2021 and held it in 3 quarters.
- Wakefield Asset Management's Dynavax Technologies position peaked at $828K in Q4 2023.
- 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.
Based on Wakefield Asset Management's 13F filing for Q2 2024, filed 5 Aug 2024.